This policy brief describes tariffs and NTBs and the relationship between these trade-related barriers and access to essential drugs. It explores current efforts to reduce these barriers and proposes policy and advocacy recommendations

Over the past three decades the non-tariff barriers to trade have grown in importance inversely to the import duties which have been lowered under GATT auspices. In the current GATT negotiations - the Tokyo round in which the contracting parties have been at work since the autumn of 1973 to...